Control Bionics (ASX:CBL) Preferred Stock: A$0.00 Mil (As of Dec. 2025)


What is Control Bionics Preferred Stock?

Control Bionics ASX:CBL +4.29% Preferred Stock is A$0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Preferred stock is a special equity security that has properties of both equity and debt. Control Bionics's preferred stock for the quarter that ended in Dec. 2025 was A$0.00 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. Control Bionics's Enterprise Value for the quarter that ended in Dec. 2025 was A$22.31 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. Control Bionics's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.02.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). Control Bionics's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was A$-0.01.

Control Bionics  (ASX:CBL) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

Control Bionics's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

Enterprise Value
=Market Cap+Preferred Stock+Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation+Minority Interest
=25.129682+0+0.02+0.218+0
-Cash, Cash Equivalents, Marketable Securities
-3.057
=22.31

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

Control Bionics's Book Value per Share for the quarter that ended in Dec. 2025 is calculated as

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (Diluted Average)
=(7.729-0)/411.962
=0.02

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

Control Bionics's Earnings per Share (Diluted) (EPS) for the six months ended in Dec. 2025 is calculated as

Earnings per Share (Diluted)=(Net Income-Preferred Dividends)/Shares Outstanding (Diluted Average)
=(-3.609-0)/331.117
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Preferred Stock Related Terms

Control Bionics Preferred Stock Historical Data

* Premium members only.

The historical data trend for Control Bionics's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Preferred Stock Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Preferred Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Control Bionics Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.

Frequently Asked Questions Learn more about Preferred Stock →
What does a Preferred Stock of A$0.00 Mil mean?
Control Bionics (ASX:CBL) has a Preferred Stock of A$0.00 Mil as of Dec. 2025. Preferred Stock represents the par value of a company's preferred shares. View historical data on Control Bionics and its competitors.
Is Control Bionics' Preferred Stock too high?
Control Bionics' current Preferred Stock is A$0.00 Mil.
How does Control Bionics' Preferred Stock compare to ABT and SYK?
Control Bionics' Preferred Stock of A$0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Stock for a Medical Devices & Instruments company?
A good Preferred Stock depends on the Medical Devices & Instruments industry context. However, Preferred Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Stock mean?
A high Preferred Stock can signal that a stock is expensive relative to its fundamentals. Preferred Stock represents the par value of a company's preferred shares. View historical data on Control Bionics and its competitors. Control Bionics's current Preferred Stock is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.07 — trading 143.3% above its estimated fair value. The current Preferred Stock is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Stock calculated?
Preferred Stock is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Preferred Stock is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.